Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ChemoMetec A/S maintains FY 2013/2014 financial guidance


Thursday, 15 May 2014 02:30am EDT 

ChemoMetec A/S:Says it has maintained its expectations for FY 2013/2014 revenue of between 43 mln Danish crowns and 45 mln crowns and FY 2013/2014 operating profit (EBITDA) in a range of between 6 mln crowns and 8 mln crowns. 

Company Quote

6.6
-0.3 -4.35%
3:29am EST